Parliamentary Bulletin

20 October 1997

Medicines and Related Substances Control Amendment Bill

This Bill provides for the supply of more affordable medicines to the people of South Africa, and for the tightening up of safety regulations concerning the manufacture, preparation and dispensing of medicines in South Africa.

The Supply of Medicines in South Africa

Under present legislation, only medicines registered in South Africa can be imported and supplied to pharmacies, hospitals and patients. It is not currently possible for pharmacies to obtain or dispense 'generically equivalent' medicines - medicines which contain the same active ingredients and are identical in dose or concentration and dosage form to the registered, branded medicines, but which are usually considerably cheaper.

Parallel Importation

The Bill proposes to allow the 'parallel importation' of medicines, which means buying an identical product made by the same company, but from a location other than where the South African distributor purchases it - and at a lower price.

It will also be permissible to import medicines not currently registered in South Africa if they are generically equivalent (ie identical in every way except name) to medicines already registered in South Africa.

South Africa recognises the intellectual property rights of manufacturers of patented medicines and will only parallel import from countries and companies which also recognise patent rights and which include the accepted patent cost in the overall price of the generic equivalent medicine.

Prescribing Generically Equivalent Medicines

Doctors and other health professionals issuing prescriptions will be permitted to prescribe generically equivalent medicines, instead of branded medicines. Moreover, whenever a person takes a prescription to a pharmacist, the pharmacist will have the following obligations:

A pharmacist will not be permitted to dispense a generically equivalent medicine if:

Pricing Committee

A pricing Committee is to be established to advise the Minister on a transparent pricing system for all medicines, to monitor the pricing of medicines and advise on an appropriate dispensing fee.

Bonusing and Sampling

Bonusing is an incentive system used by pharmaceutical companies to encourage pharmacists or other licensed dispensers to supply their medicine in preference to another. Sampling is a system under which manufacturers, wholesalers or agents supply free medicines to pharmacists or other licensed dispensers.

Both bonusing and sampling will be banned, as will any other rebate system or incentive scheme.

Code of Ethics

A code of ethics will be prescribed by the Minister relating to the marketing policies of pharmaceutical companies.

Safety Regulations

In order to improve safety, while at the same time improving efficiency, new regulations will:

Key Political Messages